MedPath

SERAX TAB 30MG

SERAX TAB 30MG

Discontinued
DIN Number

00231363

Drug Class

Human

Market Date

Dec 31, 1972

Company
HC

wyeth ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00231363
AIG Number0102420001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA04 OXAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXAZEPAMActive
Strength: 30 MG / TAB
Monograph: OXAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.